MANGINA SRINIVAS RAO's most recent trade in Balaxi Pharmaceuticals Ltd. was a Buy of 10,000 Warrants done at an average price of Rs. 112.8 . Disclosure was reported to the exchange on Oct. 14, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for MANGINA SRINIVAS RAO in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balaxi Pharma | MANGINA SRINIVAS RAO | Director | Buy | 14 Oct 2022 | 10,000 | 10,000 (0%) | - | 112.8 | 1,127,500 | 11 Oct 2022 11 Oct 2022 |
Insider Trading (-) | Warrants | Preferential Offer |
| Balaxi Pharma | MANGINA SRINIVAS RAO | Director | Sell | 31 Jan 2023 | 5,000 | 5,000 (0%) | - | 338.3 | 1,691,250 | 27 Jan 2023 27 Jan 2023 |
Insider Trading (-) | Warrants | Conversion of security |
| Balaxi Pharma | MANGINA SRINIVAS RAO | Director | Buy | 31 Jan 2023 | 5,000 | 5,000 | - | 338.3 | 1,691,250 | 27 Jan 2023 27 Jan 2023 |
Insider Trading (-) | Equity Shares | Conversion of security |
| Balaxi Pharma | MANGINA SRINIVAS RAO | Director | Buy | 18 Mar 2024 | 5,000 | 10,000 | - | 338.3 | 1,691,250 | 15 Mar 2024 15 Mar 2024 |
Insider Trading (-) | Equity Shares | Conversion of security |
| Balaxi Pharma | MANGINA SRINIVAS RAO | Director | Sell | 18 Mar 2024 | 5,000 | - (0%) | - | 338.3 | 1,691,250 | 15 Mar 2024 15 Mar 2024 |
Insider Trading (-) | Warrants | Conversion of security |